| Net Cash Provided by (Used in) Operating Activities |
$33,867 |
USD |
-14% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$33,867 |
USD |
50% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$0 |
USD |
|
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
500,000,000 |
shares |
0% |
Q4 2025 |
FY 2025 |
| Common Stock, Shares, Issued |
100,521,335 |
shares |
0% |
Q4 2025 |
FY 2025 |
| Common Stock, Par or Stated Value Per Share |
0.001 |
USD/shares |
0% |
Q4 2025 |
FY 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$0 |
USD |
|
Q4 2025 |
FY 2025 |
| Deferred Tax Assets, Valuation Allowance |
$76,680 |
USD |
19% |
Q4 2025 |
FY 2025 |
| Deferred Tax Assets, Gross |
$76,680 |
USD |
19% |
Q4 2025 |
FY 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$76,680 |
USD |
19% |
Q4 2025 |
FY 2025 |
| Preferred Stock, Shares Authorized |
5,000,000 |
shares |
|
Q3 2025 |
Q3 2025 |
| Additional Paid in Capital |
$202,113 |
USD |
2.2% |
Q4 2025 |
FY 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$0 |
USD |
|
Q4 2025 |
FY 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0.001 |
USD/shares |
|
Q3 2025 |
Q3 2025 |